Nobivac^® Rabies

The UK is fortunately free of terrestrial rabies, however specific rules apply for pet travel overseas, and will vary depending on the country. However, for dogs, cats and ferrets vaccination against rabies with an approved vaccine is one requirement common to all international pet travel. For further information on essential requirements for taking pets overseas, please visit the DEFRA web pages on this topic.

Presentation

Light yellow/orange to slightly red/purple suspension for injection with a whitish sediment.

Active ingredients

Nobivac Rabies is an inactivated vaccine containing ≥ 0.95 AIU* equivalent to ≥ 2 IU** rabies virus strain Pasteur RIV per 1ml dose. It also contains aluminium phosphate as an adjuvant and 0.1mg thiomersal as a preservative.

* Batch control is performed with an in vitro potency test according to Ph. Eur. monograph 451. AIU = rabies antigenic mass AlphaLISA International Units.

** Corresponding potency in the in vivo mouse challenge test according to Ph. Eur. Monograph 451.

Target species

Cat, dog

Indications for use

Nobivac Rabies is indicated for the active immunisation against rabies to reduce clinical signs and mortality.

Onset of immunity for dogs and cats: an adequate serological response ((insert greater than or equal to sign) 0.5 IU) has been demonstrated 2 to 3 weeks after vaccination.

Duration of immunity for dogs and cats: 3 years.

Limited safety data for ferrets are available from monitoring post vaccination reactions.
Ferrets can be vaccinated subcutaneously from 12 weeks of age.
An adequate serological response (≥0.5 IU) has been demonstrated 1 month after vaccination and they should receive a booster vaccination every 18 months.

Packaging

A cardboard box with 1 x 1 ml vials or plastic box with 10 x 1 ml vials. Type I glass vial closed with rubber stopper and aluminium cap.

Legal category

POM-V

Date of preparation: January 2022